S&P 500   4,574.79
DOW   35,756.88
QQQ   379.81
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.81
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.81
S&P 500   4,574.79
DOW   35,756.88
QQQ   379.81

Merck & Co., Inc. Social Media Sentiment

$82.38
+0.13 (+0.16 %)
(As of 10/27/2021 09:14 AM ET)
Add
Compare
Today's Range
$82.12
$82.41
50-Day Range
$71.68
$83.10
52-Week Range
$70.89
$85.60
Volume391 shs
Average Volume12.28 million shs
Market Capitalization$208.53 billion
P/E Ratio37.62
Dividend Yield3.18%
Beta0.41

Reddit Posts Over Time

wallstreetbets Posts Over Time

Media Mentions Over Time



View Trending Media Stocks

MarketBeat New Follows Over Time



View Trending Stocks on MarketBeat

MarketBeat Searches Over Time



Google Searches Over Time


Social Media Mentions

Recent Reddit Threads

October 23rd, 2021  3:27 PM  |  ZeroToHeroInvest |  options
Some TA on some stocks I have on a watchlist for the next week(s)

Im doing some research every end of week and I go through stocks to create a shortlist. Some can be plays for next week, others can be swing trades. This is part of what I have for next week, let me know if you find this useful. Feel free to jump in with ideas/comments, …

October 4th, 2021  10:31 AM  |  sarfaraj_patel786 |  Daytrading
Best performing large cap stocks in today's early trading

Guardant $GH Sasol $SSL China Eastern $CEA China Southern $ZNH Cenovus $CVE General Motors $GM Ford $F Halliburton $HAL Devon $DVN Merck $MRK DuPont $DD Southwest $LUV Suncor $SU $EOG Lumen $LUMN Vedanta $VEDL Tesla $TSLA

October 1st, 2021  6:18 PM  |  kmsjo |  wallstreetbets
$VIR - Can you make sense of it?

Ive got 600 shares of $VIR. Been averaging down like a boss. But wtf is the story here? Good news, good contracts, and $VIR keeps sliding, and then $MRK comes out with this pill Molnupiravir with efficacy of like 50% from what I read - but its BTFO by sotrovimabs …

October 1st, 2021  1:20 PM  |  mikeyrocksin2021 |  stocks
‘This is a profound game changer’: Merck’s antiviral pill cuts risk of COVID-19 hospitalization and death in half, data show

Merck cheered investors and healthcare experts alike on Friday with the news that its COVID-19 antiviral cut the risk of hospitalization or death by roughly half in a late-stage trial, and could become a powerful tool in reining in the pandemic. The drug company MRK, 9.27% …

August 31st, 2021  9:05 AM  |  jobsineachstate |  WallStreetbetsELITE
SLS has 3 PT from $16.50-$21, Shouldn't be anywhere close to $146 million market cap

$SLS has three PT from $16.50-$21 but the shorts have been holding it down for way too long after all the volume on 12/10 and 2/3... its ready to get into the next trading range which is $40-$70 because there is zero resistance from the lack of volume on the drop in June of 2019. They …

August 30th, 2021  5:52 PM  |  stillness0072 |  investing
Amarin will be at Munich Heart Congress Sept 17th & 18th

$AMRN and $PFE will be at Munich Heart Congress Sept 17th & 18th Link The way Amarin is not promoting Vazkepa going on sale on Sept 1st, Or Germanys launch party 12 days from now, and now the Munich Heart Congress means one of 2 things. 1. They are comepletly inept. …

August 30th, 2021  5:47 PM  |  stillness0072 |  pennystocks
Amarin will be at Munich Heart Congress Sept 17th & 18th

$AMRN and $PFE will be at Munich Heart Congress Sept 17th & 18th Link The way Amarin is not promoting Vazkepa going on sale on Sept 1st, Or Germanys launch party 12 days from now, and now the Munich Heart Congress means one of 2 things. 1. They are comepletly inept. …

August 30th, 2021  5:38 PM  |  stillness0072 |  StockMarket
Amarin will be at Munich Heart Congress Sept 17th & 18th

$AMRN and $PFE will be at Munich Heart Congress Sept 17th & 18th Link The way Amarin is not promoting Vazkepa going on sale on Sept 1st, Or Germanys launch party 12 days from now, and now the Munich Heart Congress means one of 2 things. 1. They are comepletly inept. …

August 30th, 2021  5:37 PM  |  stillness0072 |  wallstreetbets
Amarin will be at Munich Heart Congress Sept 17th & 18th

Amarin will be at Munich Heart Congress Sept 17th & 18th The way Amarin is not promoting Vazkepa going on sale on Sept 1st, Or Germanys launch party 12 days from now, and now the Munich Heart Congress means one of 2 things. 1. They are comepletly inept. (I doubt …

August 30th, 2021  5:29 PM  |  stillness0072 |  wallstreetbets
Amarin will be at Munich Heart Congress Sept 17th & 18th

Amarin will be at Munich Heart Congress Sept 17th & 18th Link The way Amarin is not promoting Vazkepa going on sale on Sept 1st, Or Germanys launch party 12 days from now, and now the Munich Heart Congress means one of 2 things. 1. They are comepletly inept. (I doubt …

August 30th, 2021  5:26 PM  |  stillness0072 |  stocks
$AMRN and $PFE will be at Munich Heart Congress Sept 17th & 18th

$AMRN and $PFE will be at Munich Heart Congress Sept 17th & 18th Link The way Amarin is not promoting Vazkepa going on sale on Sept 1st, Or Germanys launch party 12 days from now, and now the Munich Heart Congress means one of 2 things. 1. They are comepletly inept. …

August 28th, 2021  8:36 AM  |  stillness0072 |  wallstreetbets
Covid results of Amarin's drug on Aug 29th at ESC Congress

Results from the clinical trial(Prepare-IT) of ($AMRN) Amarins drug Vascepa will be presented this coming Sunday(Aug 29th) at ESC Congress(European Society of Cardiology). In the late breaking COVID results. Could be a game changer for hospital treatment of COVID. Only time will tell. The …

July 31st, 2021  5:42 PM  |  LazyMoneyGame |  dividends
July dividends 2021

Now it´s time for the monthly update on the portfolio. So lets start with the dividend payers this month 11.13 LTC 51.43 SJI 110.50 MRK 165.24 STOR 16.86 CAH 37.67 SPG $392.85 Total (The numbers are after 15% withholding tax) So that is really big increase from the $56.25 …

July 29th, 2021  2:43 AM  |  kribz666 |  smallstreetbets
Biggest Companies Releasing Earnings Today

This week is heavy on earnings! Here are some numbers about companies with +100B $ market cap releasing earnings today and tomorrow: $MRK: Healthcare \- Average historic mvt: 2.7% - standard dev. historic mvts: 1.4% - Last move: 2.9% $TMUS: Communication Services \- Average historic …

This page was last updated on 10/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.